Analysts: McDonald’s Risk/Reward is Favorable and 3 More Research Notes to Check Out

McDonald’s (NYSE:MCD): Stephens views McDonald’s risk/reward profile as very favorable, and believes that it is the best-positioned large QSR in this environment. The firm thinks that new products will drive improving same-store sales, and rates the shares at with a $120 price target.


Isis Pharmaceuticals (NASDAQ:ISIS): Piper Jaffray has downgraded Isis Pharmaceuticals to Underweight citing valuation, though it raised its price target for shares to $20 from $12.


Hershey (NYSE:HSY): Citigroup has added Hershey to its Top Picks Live list and raised its price target for shares to $110 from $100 just ahead of the company’s quarterly results on Wednesday. Citi is expecting the company to post broad-based revenue growth and reiterates a Buy rating on the stock.


Merck & Co. (NYSE:MRK): Citigroup believes that the valuation of Merck shares and consensus estimates for the company are not reflecting its deteriorating revenue and earnings outlook. The firm notes that the stock is “more expensive than the market believes” and reiterates a Neutral rating on Merck.


Investing Insights: Can Celgene Continue Its Impressive Growth?